NRP1 and metastatic neoplasm: A recent study demonstrated that iRGD-modified nanoworms significantly affected tumor progression in the early stages of metastasis, which might be regulated by binding NRP-1, with no or minor effect on primary tumors, whereas free iRGD peptide did not significantly inhibit primary and metastatic tumors (Hamilton et al., 2015).